of the patients included in these two datasets have been published in our previous reports 2, 6 . The Royal Perth Hospital is a university teaching hospital and is Western Australia's largest trauma centre. It admits about 4000 to 6000 adult trauma patients per annum, including burns, cardiothoracic, spinal and head trauma. The standard VTE prophylaxis for all injured patients included elastic stockings, intermittent pneumatic compression to lower limbs when there were no injuries to the legs 7 and unfractionated heparin (5000 units twice or three times per day). Low molecular weight heparin, in the form of subcutaneous enoxaparin 40 mg daily, was also used occasionally in patients who were deemed to be not at risk of bleeding. Since 2006, retrievable IVC filters were used as primary VTE prophylaxis if pharmacologic VTE prophylaxis was contraindicated because of bleeding risk and intermittent pneumatic compression to the lower limbs was not possible due to lower limb injuries 7,8 ; or when using intermittent pneumatic compression alone for a prolonged period of time was considered inadequate to prevent fatal PE (e.g. a patient with pelvic fractures, abdominal visceral organ injury and severe brain injury requiring multiple operations within the first seven to ten days after the injury). IVC filters were used for secondary VTE prophylaxis in patients who had documented symptomatic VTE but had contraindications to systemic anticoagulation. Regular lower limb Doppler ultrasound surveillance for deep vein thrombosis (DVT) was not part of usual clinical care and ultrasound of the deep veins was performed only when DVT was suspected clinically.
The first dataset contained 134 consecutive patients who died after major trauma between 1994 and 2002 with accurate information on the causes of death including those who succumbed to fatal PE 2 . The patients who succumbed to fatal PE were misdiagnosed as having other causes of cardiovascular or respiratory disorders until the cause of death was confirmed by a post mortem examination. The second dataset contained 224 consecutive patients who required an IVC filter between 2007 and 2012 for either primary or secondary VTE prophylaxis due to contraindications to pharmacologic VTE prophylaxis or treatment, respectively 6 . Both datasets contained the five variables needed by the TESS to calculate the predicted risk of VTE. The clinical information recorded within the first 24 hours of trauma admission prior to the occurrence of VTE was used to generate the predicted risk of VTE by the TESS for each patient in this study. Missing data on body mass index occurred in six patients (1.7%) in the latter dataset and the TESS obesity score of these patients was assumed to be zero in this study. All VTE outcome events included in these datasets were symptomatic DVT and PE confirmed by colour Doppler compression ultrasound and computed tomography pulmonary angiography or post mortem examination, respectively.
Statistical analysis
Categorical variables and continuous variables with skewed distributions were analysed using chi-square and Mann-Whitney U tests, respectively. We used the area under the receiver-operating-characteristic (ROC) curve to assess the ability of the TESS to discriminate between patients who developed VTE and those who did not. In this study, an area under the ROC curve >0.80, between 0.7 and 0.8, between 0.6 and 0.7, and below 0.6 were considered good, moderate, satisfactory, and unsatisfactory, respectively.
Calibration of a prognostic model indicates how well the predicted risks agree with the observed risks across the full spectrum of predicted risks and it is vital to assessing the utility of a prognostic model 9, 10 . In this study, we used a calibration plot to compare the observed and predicted risks of VTE to assess the calibration of the TESS. The slope and intercept of the calibration curve were also calculated 10, 11 . A calibration curve with a slope of 1 and an intercept of 0 would indicate perfect calibration. If the slope of the TESS calibration curve was <1, it indicated that the predicted risks of VTE were too extreme, with the TESS underestimating VTE of the low-risk strata and overestimating VTE of the high-risk strata. Conversely, if the slope was >1, this indicated that the predicted risks of VTE were not sufficiently different across the risk strata. An intercept <0 indicated that the predicted risks of VTE were systematically too high and an intercept >0 indicated that the predicted risks of VTE were systematically too low. Because the intercept would be affected by the slope of the calibration curve, the intercept was estimated with the slope set to 1 as a standard procedure 10, 11 . The calibration of the model was also assessed by the Hosmer-Lemeshow chi-square statistics, with a P-value <0.05 suggestive of imperfect calibration. Using a TESS predicted risk of 5% as an arbitrary cut-point, sensitivity, specificity, negative and positive predictive values of the TESS were calculated to assess whether this cut-point could be used to exclude VTE or fatal and non-fatal PE. In this study, a P-value <0.05 was deemed significant and all statistical analyses were two-tailed and performed using SPSS for Windows (version 19.0, IBM, Armonk, NY, USA).
RESULTS
Of the 357 patients included in this study, 74 patients (21%, 95% confidence interval [CI] 17 to 25) developed symptomatic VTE (median time to VTE 14 days post-trauma admission; interquartile range 6 to 27). There were in total 16 fatal PE, 22 non-fatal PE and 47 DVT events in 74 patients ( Figure 1 ). Of these 74 patients who had at least one episode of a VTE event, three patients had all three forms of VTE (PE, upper and lower limb DVT), three patients had both upper and lower limb DVT and two patients had both lower limb DVT and PE.
Patients who developed symptomatic VTE were slightly older (42 versus 31 years old), more likely to require mechanical ventilation (100% versus 81%) and had a higher body mass index (30 versus 26) compared to those who did not develop symptomatic VTE (Table  1) . Lower limb injury and Injury Severity Score were not significantly different between those who developed symptomatic VTE and those who did not. The TESS score (11 versus 9) and predicted risks of VTE (14% versus 9%) were both significantly higher among those who developed symptomatic VTE. However, the patients who did not develop symptomatic VTE had a lower admission Glasgow Coma Scale Score and features of more severe traumatic brain injury on the computed tomography brain scan compared to those who developed symptomatic VTE. This was likely due to the inclusion of all patients who died from severe traumatic brain injury in one of the two datasets.
The ability of the TESS to discriminate between patients who developed symptomatic VTE and those who did not was moderate (area under the ROC curve 0.71, 95%, CI 0.65 to 0.77). The ability of the TESS to discriminate between patients who developed fatal or non-fatal PE and those who did not was satisfactory, but appeared not as good in predicting all symptomatic VTE events (area under the ROC curve 0.67, 95%, CI 0.59 to 0.75). In terms of calibration, the Hosmer-Lemeshow chi-square statistic was 13.7 (P=0.008), suggesting that the model was not well-calibrated. The slope and intercept (after setting the slope to 1) of the calib-ration curve were 2.76 (standard error 0.44) and 0.34 (standard error 0.15), respectively. This suggested that the TESS predicted risks of symptomatic VTE were not sufficiently extreme and the model overall underestimated the observed risks of symptomatic VTE in this cohort of patients ( Figure  2 ). Using 5% TESS predicted risk of VTE (TESS score <9) as an arbitrary cut-point, the TESS had a highsensitivity and negative predictive value in excluding symptomatic VTE, fatal and non-fatal PE (Table 2a,  2b, 2c) . The specificity and positive predictive value were, however, relatively low.
DISCUSSION
This study showed that the TESS had a moderate ability to discriminate between major trauma patients who developed symptomatic VTE and those who did not. Although TESS was not well-calibrated in predicting risks of symptomatic VTE across the full spectrum of severely injured patients, it had a very high sensitivity and negative predictive value in excluding symptomatic VTE, fatal and non-fatal PE. These results are clinically important and require careful consideration.
First, previous studies showed that the incidence of VTE in severe trauma patients could be as high as 26%, despite VTE prophylaxis 12, 13 , which is consistent with the risk of symptomatic VTE reported in this study (21%). It is important to recognise that the patients included in this study were not general trauma patients but patients who were at extreme risk of VTE after very severe trauma with a median Injury Severity Score well over 30. Patients who died from their injury and also those who required an IVC filter were more likely to have omission of pharmacologic VTE prophylaxis within the first two weeks after their injuries than general trauma patients. This could explain, at least in part, why the observed risks of VTE in our patients were higher than the TESS predicted risks of VTE. Second, our results showed that the TESS had a moderate ability to discriminate between patients who developed symptomatic VTE and those who did not. This suggests that the TESS can be useful in assessing the balance of baseline VTE risk between control and intervention groups in a randomised, controlled trial comparing different strategies of VTE prophylaxis and also possibly the external validity of the trial results. We also confirmed that the TESS has a high sensitivity and negative predictive value in excluding symptomatic VTE 5 . The risk of symptomatic VTE including fatal and non-fatal PE was small when we used TESS predicted risk of VTE <5% as an arbitrary cut-point (TESS score <9). This threshold of VTE risk could possibly be used as a recruitment criterion for randomised, cont-rolled trials comparing different strategies of VTE prophylaxis for patients at high risk of VTE or when clinicians are considering using IVC filters for primary VTE prophylaxis in severe trauma patients who have contraindications to other forms of VTE prophylaxis. If our results can be confirmed by other studies, using IVC filters for primary VTE prophylaxis after trauma is unlikely to be cost-effective if the TESS predicted risk of patients is <5%.
TESS-predicted risks of venous thromboembolism (%) Observed risks of venous thromboembolism
The last consideration is the limitations of this study. Firstly, this was a single-centre study and the sample size was relatively small, limiting the external validity and precision of the results, respectively. Secondly, we only had data on symptomatic VTE and, as such, the performance of the TESS in predicting asymptomatic VTE remains uncertain. Thirdly, we had pooled all VTE events as an outcome in assessing the discrimination and calibration of the TESS. Recent evidence suggests that risk factors for the various forms of VTE may be different 14 . Whether the discrimination and calibration of the TESS in predicting upper limb DVT is similar to lower limb DVT or PE remains uncertain, but this warrants further investigation. Finally, it should be emphasised that this study only included severely injured patients who were at extreme risk of VTE and mortality and hence, our results may not be generalisable to patients with more minor trauma.
CONCLUSION
When applied to patients who either died after major trauma or had contraindications to anticoagulants and required an IVC filter for VTE prophylaxis, the TESS had a moderate ability to discriminate between patients who developed symptomatic VTE and those who did not. Although the calibration of the TESS was not perfect when applied to patients who were at extreme risk of VTE, its high sensitivity and negative predictive value may still be useful for clinical and research purposes.
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